In a significant move aimed at enhancing public health, the United States Environmental Protection Agency (EPA) has proposed the inclusion of microplastics and pharmaceuticals on its Contaminant Candidate List (CCL) for drinking water. This proposal, unveiled on 2 April 2026, marks the first time these substances have been classified as potential contaminants, paving the way for future regulations that could limit their presence in public water supplies.
A Response to Public Concerns
EPA Administrator Lee Zeldin highlighted the agency’s commitment to addressing the growing worries of Americans regarding the safety of their drinking water. “I can’t think of an issue that hits closer to home for American families than the safety of their drinking water,” Zeldin stated during the announcement at EPA headquarters in Washington, D.C. This initiative is also seen as a victory for Robert F. Kennedy Jr.’s Maha movement, which has been advocating for stricter environmental regulations.
The CCL serves as a framework for the EPA to identify and prioritise contaminants that are not currently regulated under the Safe Drinking Water Act (SDWA). The draft of the sixth iteration of this list opens a 60-day window for public comments, with a finalised version expected by mid-November.
The Health Implications of Microplastics and Pharmaceuticals
Research into the impacts of microplastics, which are small plastic particles resulting from the breakdown of larger plastic items, has revealed their presence not only in drinking water but also in human organs such as the heart, brain, and testicles. While the full extent of health risks associated with microplastics remains under investigation, experts express growing concern. Similarly, pharmaceuticals that enter the water supply through human excretion pose significant challenges, as conventional wastewater treatment processes often fail to eliminate these substances effectively.
Dr Philip Landrigan, director of the Global Observatory on Planetary Health at Boston College, emphasised the necessity of addressing the root causes of plastic pollution alongside regulatory measures. “If the United States does not rein in the accelerating growth in plastic production, which leads to plastic pollution, it will make little difference,” he warned.
The Road Ahead: Regulatory Challenges and Activism
Despite the positive step represented by the proposed CCL update, scepticism remains about the EPA’s ability to implement substantial changes. Erik Olson, a senior attorney with the Natural Resources Defense Council, remarked, “It’s the beginning of a very long process that routinely ends in nothing.” Advocates for stronger regulations, including Judith Enck, former EPA regional administrator, view the listing as a preliminary measure that could eventually lead to the regulation of microplastics within public water supplies.
Food & Water Watch has called for comprehensive monitoring measures to accompany the listing, while the American Chemistry Council expressed conditional support for standardised monitoring of microplastics, highlighting the need for consistent data collection across the nation.
The collaboration between the EPA and Kennedy’s Maha movement indicates a shift towards a more proactive stance on environmental contaminants. However, activists have expressed frustration over the slow pace of regulatory action, particularly concerning pesticide regulation and the production of harmful chemicals.
Future Initiatives and the Push for Change
In conjunction with the proposed CCL update, the EPA is developing a broader agenda aimed at addressing pressing environmental issues, including “forever chemicals,” food quality, and lead pipe contamination. This agenda is reportedly in its final stages, as confirmed by EPA press secretary Brigit Hirsch.
Kennedy, whose independent presidential campaign is focused on combating plastic pollution, has initiated a $144 million project named Systematic Targeting of Microplastics (Stomp). This initiative aims to develop tools for detecting and quantifying microplastics, mapping their pathways through the human body, and ultimately removing them.
Why it Matters
The EPA’s proposal to designate microplastics and pharmaceuticals as drinking water contaminants is a pivotal step towards safeguarding public health. As awareness of environmental issues continues to grow, this initiative underscores the urgent need for comprehensive regulations to protect water quality. While the path to effective regulation may be fraught with challenges, the commitment to addressing these pressing contaminants signals a crucial evolution in environmental policy, one that could have far-reaching implications for both public health and ecological sustainability.
